Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: The coronary artery calcification in Type 1 diabetes study

Diabetic Medicine

Volumn 27, Issue 12, 2010, Pages 1436-1442

  Snell Bergeon, J K ^a   Roman, R ^a   Rodbard, D ^b   Garg, S ^a   Maahs, D M ^a   Schauer, I E ^c   Bergman, B C ^c   Kinney, G L ^a   Rewers, M ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b Biomedical Informatics Consultants   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Continuous glucose monitoring; Coronary artery disease; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; CALCIUM; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; DISEASE DURATION; ELECTRON BEAM TOMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETIC ANGIOPATHY; METABOLISM; PATHOLOGY; RISK FACTOR; SEX RATIO;

ADULT; BLOOD GLUCOSE; CALCIUM; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RISK FACTORS; SEX DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953064502     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03127.x     Document Type: Article

References (30)

1. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006; 55: 1463-1469.
2. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year followup data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003; 26: 1374-1379.
3. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database. Diabetes Care 2006; 29: 798-804.
4. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003; 52: 2833-2839.
5. Costacou T, Edmundowicz D, Prince C, Conway B, Orchard TJ. Progression of coronary artery calcium in type 1 diabetes mellitus. Am J Cardiol 2007; 100: 1543-1547.
6. Rumberger JA, Sheedy PF, Breen JF, Fitzpatrick LA, Schwartz RS. Electron beam computed tomography and coronary artery disease: scanning for coronary artery calcification. Mayo Clin Proc 1996; 71: 369-377.
7. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003; 107: 2571-2576.
8. Snell-Bergeon JK, Hokanson JE, Jensen L, Mackenzie T, Kinney G, Dabelea D et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 2003; 26: 2923-2928.
9. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
10. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 2006; 55: 3556-3565.
11. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996; 45: 1253-1258.
12. Larsen JR, Brekke M, Bergengen L, Sandvik L, Arnesen H, Hanssen KF et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005; 48: 776-779.
13. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999; 42: 926-931.
14. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239.
15. Kovatchev B, Anderson S, Heinemann L, Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 2008; 31: 1160-1164.
16. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S et al. Improvement in glycemic excursions with a transcutaneous, realtime continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006; 29: 44-50.
17. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2006; 114: 63-67.
18. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476.
19. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33: S11-S61.
20. Rodbard D. New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 2009; 11: 551-565.
21. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009; 11: S55-S67.
22. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832.
23. Kilpatrick ES, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem 2007; 53: 897-901.
24. Kilpatrick ES, Rigby AS, Atkin SL. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2008; 51: 365-371.
25. Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009; 32: 1901-1903.
26. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-1354.
27. Kilpatrick ES. Arguments for and against the role of glucose variability in the development of diabetes complications. J Diabetes Sci Technol 2009; 3: 649-655.
28. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M et al. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 2002; 22: 438-442.
29. Jain SK, Rogier K, Prouty L, Jain SK. Protective effects of 17b-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: relevance to heart disease in postmenopausal women. Free Radic Biol Med 2004; 37: 1730-1735.
30. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000; 49: 1571-1578.